Adjuvant chemotherapy for breast cancer.
D000367:Age Factors; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008207:Lymphatic Metastasis; D008558:Melphalan / Q000627:therapeutic use; D008593:Menopause; D008875:Middle Aged; D011379:Prognosis; D013852:Thiotepa / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004317:Doxorubicin; D003520:Cyclophosphamide; D013852:Thiotepa; D008558:Melphalan; D005472:Fluorouracil